EUVIMEDOpdag EUVIMED
Crossref

The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques

Adèle Dhuyser iD, Michaël Pérès, Thomas Morel, Sandra Clément, Alice Aarnink

HLA · 2025

DOI: 10.1111/tan.70102 ↗

At a glance

Journal article in HLA, 2025. Written by Adèle Dhuyser and 4 co-authors. Institution: HLA and Histocompatibility Laboratory, CHRU de Nancy, Vandœuvre-lès-Nancy, France. Major MEDLINE topics: HLA-DRB1 Chains, Alleles, Histocompatibility Testing, Exons. Cited 2 times so far (Crossref); 4 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The novel allele HLA‐DRB1*13:348 differs from HLA‐DRB1*13:02:01:01 by one non‐synonymous nucleotide substitution in exon 2.

Subjects

MeSH terms (MEDLINE)

HLA-DRB1 ChainsAllelesHistocompatibility TestingExonsHumansSequence Analysis, DNABase SequenceSequence Alignment

Author keywords

HLAHLA‐DRB1nanotype sequencingnovel allelesequencing‐based typing

Substances

HLA-DRB1 ChainsHLA-DRB1*13 antigen

Authors and institutions

  • HLA and Histocompatibility Laboratory, CHRU de Nancy, Vandœuvre-lès-Nancy, France.
  • IMoPA, UMR7365 CNRS, Université de Lorraine, Vandœuvre-lès-Nancy, France.

ORCID profiles: Adèle Dhuyser

Cite

APA

Dhuyser, A., Pérès, M., Morel, T., Clément, S., & Aarnink, A. (2025). The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques. HLA. https://doi.org/10.1111/tan.70102

Vancouver

Dhuyser A, Pérès M, Morel T, Clément S, Aarnink A. The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques. HLA. 2025. doi:10.1111/tan.70102

BibTeX
@article{Dhuyser2025,
  author = {Dhuyser, Adèle and Pérès, Michaël and Morel, Thomas and Clément, Sandra and Aarnink, Alice},
  title = {The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques},
  journal = {HLA},
  year = {2025},
  doi = {10.1111/tan.70102}
}
Start for free →